The acquisition of Paragonix Technologies contributed significantly, with a 65% net sales growth in Q4, enhancing Getinge AB's position in the organ transport market. Free cash flow increased by more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback